SEE Program Strengthens Adherence - Summary - MDSpire

SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence and reduces stress in randomized trial

  • By

  • Alun Evans

  • March 4, 2026

  • 3 min

Share

Objective:

To evaluate the effectiveness of a structured, motivational interviewing-based coaching program on medication adherence and glaucoma-related distress.

Approach:
    Key Findings:
    • SEE group showed significantly higher adherence (mean 78%) compared to controls (mean 58%).
    • 55% of SEE participants achieved at least 80% adherence, versus 24% of controls.
    • The intervention led to a meaningful reduction in glaucoma-related distress, particularly in emotional burden and regimen-related distress.
    Interpretation:

    The SEE program demonstrates that personalized, motivational interviewing-based coaching can effectively enhance medication adherence and reduce distress in glaucoma patients.

    Limitations:
    • The study was conducted at two specific health systems, which may limit generalizability.
    • Long-term effects beyond the 6-month period were not assessed.
    Conclusion:

    The findings support the use of multifaceted, personalized interventions for improving adherence and reducing distress in glaucoma management.

    Sources:

Original Source(s)

SEE Program Strengthens Adherence

  • by Alun Evans

  • March 4, 2026

Related Content

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

Small Copy Number Neutral Intrachromosomal Translocation of PAX6 and Aniridia

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.